Rare diseases
Investigational molecules
Locations
2 Avenue Martin Luther King, 87042 Limoges, France
Centre Hospitalier Et Universitaire De Limoges in Limoges, France specialises in clinical trials of conditions such as Non-small cell lung cancer, Plasma cell myeloma, Acute myeloid leukaemia, Hormone receptor positive HER2 negative breast cancer, and other specialisations. This site conducts important research.
The clinical trial activity at Centre Hospitalier Et Universitaire De Limoges focuses on oncology, with a strong emphasis on lung cancer care within the thoracic oncology unit. The studies are centered on improving treatment options for extensive stage small cell lung cancer, a fast-growing and difficult-to-treat disease.
Overall, the research here is aimed at testing whether new cancer therapies can improve survival and provide better outcomes for people with advanced neoplasms.
Clinical trials currently enrolling participants at this site.
Phase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
FranceA study to evaluate the effectiveness and safety of usnoflast in adults with Amyotrophic Lateral Sclerosis (ALS)
FranceA study testing xanomeline tartrate and trospium chloride for treating agitation in patients with Alzheimer's disease
FranceStudy of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation
FranceStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
FranceStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
FranceStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
FranceStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
FranceStudy of IPH5201 and Durvalumab for Pre- and Post-Surgery Treatment in Patients with Early-Stage Non-Small Cell Lung Cancer
FranceStudy on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis
FranceStudy of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)
FranceStudy on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis
FranceMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
